Clinical Trials Logo

Filter by:
NCT ID: NCT06353243 Recruiting - Preterm Birth Clinical Trials

Bilateral Infant Stimulation Study

BLISS
Start date: February 26, 2024
Phase: N/A
Study type: Interventional

This study will investigate stress that parents of children admitted to the neonatal intensive care unit (NICU) experience. Investigation of a novel intervention of using bilateral alternating stimulation to reduce parental stress and anxiety and increase bonding/attachment in NICU. Evaluate parental stress and feelings of bonding using surveys before and after the intervention. Intervention will be done at neonate's bedside while admitted to the NICU. Vital sign data will be collected as a marker of parent and neonate's stress response during the intervention.

NCT ID: NCT06353217 Recruiting - Diabetes Mellitus Clinical Trials

Study of a Primary Care Hypoglycemia Prevention Program

Start date: May 22, 2024
Phase: N/A
Study type: Interventional

This is a single site, pre-post pilot study. The objective is to evaluate the acceptability and feasibility of a primary care hypoglycemia prevention program for patients taking hypoglycemia-causing medications. The study will also evaluate relevant process outcomes and clinical outcomes for refining the intervention and planning for a larger efficacy trial.

NCT ID: NCT06353191 Recruiting - Clinical trials for Malignant Solid Neoplasm

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

Start date: May 3, 2019
Phase:
Study type: Observational

This study evaluates why some cancer patients but not others experience changes in heart function following treatment with chemotherapy.

NCT ID: NCT06353178 Recruiting - Cancer Clinical Trials

Building Empowerment and Coping Outcomes for caNcer Patients, Survivors and Their Caregivers

BEACON
Start date: April 8, 2024
Phase: N/A
Study type: Interventional

Cancer has a psychological, emotional and social impact beyond a patient's physical health. This study examines three new online peer mental-wellness support program for cancer patients, survivors or their caregivers. Each program teaches evidence-based skills, in the context of that groups lived experience, to manage the emotional impact of cancer. This study examines the impact of that program.

NCT ID: NCT06353113 Recruiting - Depression Clinical Trials

Feasibility of a Prenatal Yoga Mobile App in African American Pregnant Women

Start date: July 2024
Phase: N/A
Study type: Interventional

The goal of this research is to test if a prenatal yoga app can improve well-being in African American/Black (AA) pregnant women. The main questions it aims to answer are: 1. Is the Down Dog prenatal yoga app feasible for AA pregnant women? 2. How does mental and physical health change after using the Down Dog app for 12-weeks? 3. What cultural adaptations to the Down Dog app are needed? The study lasts for 12 weeks and participants are asked to: - do prenatal yoga with the app for at least 20 min/day, three days/week, from home - wear a Garmin Vivosmart 5 watch daily - complete four online surveys - complete an optional virtual interview This project aims to advance public health by contributing to a broader understanding of how prenatal yoga can support the health and well-being of AA pregnant women and promote optimal maternal and child health outcomes.

NCT ID: NCT06352905 Recruiting - Parkinson Disease Clinical Trials

Acute Effects of Whole Body Vibration for Individuals With Parkinson Disease

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

This is an exploratory study to assess the impact of whole body vibration on backward walking speed in people with Parkinson disease.

NCT ID: NCT06352866 Not yet recruiting - Multiple Myeloma Clinical Trials

Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM

Start date: July 1, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine the safety, efficacy and feasibility of the use of one standard dose of siltuximab prior to teclistamab infusion. Siltuximab is an investigational (experimental) drug that works by binding directly to human interleukin-6 (IL-6). IL-6 is a cytokine; these are products that are secreted by certain cells of the immune system and effect other cells in participant's body. IL-6 regulates immune, inflammatory and metabolic processes. Siltuximab has already been tested and approved for use by the FDA in participants with a condition called multicentric Castleman's disease, which is a lymphoproliferative disorder. This study is being conducted to investigate if administration of a single dose of siltuximab will reduce the rates of and severity of Cytokine Release Syndrome (CRS) and Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS) in participants prior to teclistamab administration. CRS and ICANS are adverse effects commonly experienced by participants being treated with teclistamab that are related to inflammation in the body. Siltuximab is experimental because it is not approved by the Food and Drug Administration (FDA) for prophylactic use prior to administration of teclistamab infusion.

NCT ID: NCT06352840 Not yet recruiting - Endometriosis Clinical Trials

Novel Web-based, Self-directed Intervention for Chronic Pelvic Pain

Start date: April 2024
Phase: N/A
Study type: Interventional

The study is being completed to evaluate the effectiveness of a web-based, self-management program for patients with Chronic Pelvic Pain (CPP). The overall hypothesis is that patients with chronic pelvic pain that have access to the My Pelvic Plan program will demonstrate improvements in pain, physical function, and quality of life with this integrative self-management approach.

NCT ID: NCT06352827 Enrolling by invitation - Constipation Clinical Trials

Guideline to Implementation: A Rapid Clinical Care Pathway to Care for Patients Affected by Chronic Constipation

Start date: June 2024
Phase:
Study type: Observational

The study is being completed to test the pilot implementation of a rapid clinical care pathway for chronic constipation in the University of Michigan Gastroenterology clinic. This study will learn how often patients get better and how satisfied patients are with care decisions, when seen by a gastroenterologist for medical advice on constipation.

NCT ID: NCT06352814 Recruiting - Cerebral Palsy Clinical Trials

Activities-based Locomotor Training Program Versus Traditional Physical Therapy in Children With Cerebral Palsy

Start date: March 8, 2024
Phase:
Study type: Observational

The purpose of this study is to investigate the impact of an intensive activities-based locomotor training program as compared to traditional physical therapy on activity, participation, and central and peripheral neurophysiological adaptation in children with cerebral palsy.